Sodium Ibandronate Injection

Category:Excipients > Other Excipients
Product Name:Sodium Ibandronate Injection
CAS No.:/
Standard:In-house Standards
Price(USD):0.00
Company:Shenzhen Mellowhope Pharm Industrial Co., Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shen zheng Guangdong China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: CIF

    "1, Treatment and prevention of osteoporosis in postmenopausal women; 2, Treatment for ostealgia caused by metastatic bone cancer; 3, Treatment for the hypercalcemia caused by malignant neoplasm with or without metastatic bone cancers." "Highlights: 1, Decrease 30%~50% of the ratio and of skeletal related event (SRE), defer the occurrence time; 2, the 3rd generation of diphosphonate, more excellent penetrability makes it to be one of the most active diphosphonate; 3, Over 500,000 patients have been treated in more than 50 countries (Boniva® by Roche). 4, Time to market: 2012 5,Originator: Boniva® by Roche Registration Dossiers:non-clinical & clinical part, drug substance part and drug product part. "

Send your message to this supplier
  • From:
  • To:
    Shenzhen Mellowhope Pharm Industrial Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service